Sensory-evoked potentials of N80 and N150. by Soheila Qanbari (20455173)

Subjects:

Walking path. by Saori Miyagishima (14593506)

Subjects:

S1 Data - by Saori Miyagishima (14593506)

Subjects:

Results of XCOM and step velocity. by Saori Miyagishima (14593506)

Subjects:

Results of coefficient of regression. by Saori Miyagishima (14593506)

Subjects:

Demographic data. by Saori Miyagishima (14593506)

Subjects:

Two indicators of straight gait; XCOMG and XCOMp. by Saori Miyagishima (14593506)

Subjects:

Results of regression analysis performed for age. by Saori Miyagishima (14593506)

Subjects:

Result of multiple regression analysis. by Saori Miyagishima (14593506)

Subjects:

Fig 1 - by Skadi Wilke (2818591)

All TEAM Occupancy from Tropical mammal functional diversity increases with productivity but decreases with anthropogenic disturbance by Daniel Gorczynski (10093617)

“…Mammal community functional dispersion increased with primary productivity, while functional richness decreased with human-induced local extinctions and was significantly lower in Madagascar than other tropical regions. …”

Fig 2 - by Skadi Wilke (2818591)

The carotid canal area is larger on the unaffected side than on the affected side in patients with unilateral moyamoya disease, but the difference decreases according to the contra... by Yuki Oichi (11840776)

Image_1_The Contribution of Decreased Muscle Size to Muscle Weakness in Children With Spastic Cerebral Palsy.TIF by Britta Hanssen (4898155)

“…To define the contribution of decreased muscle size to muscle weakness, two cohorts were recruited in this cross-sectional investigation: 53 children with SCP [median age, 8.2 (IQR, 4.1) years, 19/34 uni/bilateral] and 31 children with a typical development (TD) [median age, 9.7 (IQR, 2.9) years]. …”

Table_2_The Contribution of Decreased Muscle Size to Muscle Weakness in Children With Spastic Cerebral Palsy.docx by Britta Hanssen (4898155)

“…To define the contribution of decreased muscle size to muscle weakness, two cohorts were recruited in this cross-sectional investigation: 53 children with SCP [median age, 8.2 (IQR, 4.1) years, 19/34 uni/bilateral] and 31 children with a typical development (TD) [median age, 9.7 (IQR, 2.9) years]. …”

Table_3_The Contribution of Decreased Muscle Size to Muscle Weakness in Children With Spastic Cerebral Palsy.docx by Britta Hanssen (4898155)

“…To define the contribution of decreased muscle size to muscle weakness, two cohorts were recruited in this cross-sectional investigation: 53 children with SCP [median age, 8.2 (IQR, 4.1) years, 19/34 uni/bilateral] and 31 children with a typical development (TD) [median age, 9.7 (IQR, 2.9) years]. …”

Table_1_The Contribution of Decreased Muscle Size to Muscle Weakness in Children With Spastic Cerebral Palsy.docx by Britta Hanssen (4898155)

“…To define the contribution of decreased muscle size to muscle weakness, two cohorts were recruited in this cross-sectional investigation: 53 children with SCP [median age, 8.2 (IQR, 4.1) years, 19/34 uni/bilateral] and 31 children with a typical development (TD) [median age, 9.7 (IQR, 2.9) years]. …”

Pearson’s correlations of cytokine and chemokine levels observed in AE patients are shown. by Beate Grüner (301524)

Diagram of the mechanism by which PFAS causes a decrease in constipation. by Yifan Zhao (659636)

Baseline maternal and infant demographics and clinical characteristics. by Ashenafi Shumey Cherkos (19434556)

Subjects: